Corrigendum to “Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation” [Pharmacol. Res. 159 (2020) 104944] (Pharmacological Research (2020) 159, (S1043661820312524), (10.1016/j.phrs.2020.104944))

Delong Chen; Zhen Ye; Chao Wang; Qingqing Wang; Haibin Wang; Vincent Kuek; Ziyi Wang; Heng Qiu; Jinbo Yuan; Jacob Kenny; Fan Yang; Jianbo He; Yun Liu; Gang Wang; Meng Zhang; Gangyu Zhang; Junjian Wang; Peng Chen; Jiake Xu

doi:10.1016/j.phrs.2024.107463

Corrigendum to “Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation” [Pharmacol. Res. 159 (2020) 104944] (Pharmacological Research (2020) 159, (S1043661820312524), (10.1016/j.phrs.2020.104944))

Delong Chen, Zhen Ye, Chao Wang, Qingqing Wang, Haibin Wang, Vincent Kuek, Ziyi Wang, Heng Qiu, Jinbo Yuan, Jacob Kenny, Fan Yang, Jianbo He, Yun Liu, Gang Wang, Meng Zhang, Gangyu Zhang, Junjian Wang, Peng Chen, Jiake Xu

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The authors have informed the Journal that in the article referenced above, during the course of the revision a wrong image was uploaded as Fig. 3A left panel. The Ethics Committee of the Clifford Hospital was asked by the Editor to check the integrity of the results sustaining the above referenced article. The Committee has checked the raw data and confirmed in writing to the journal the integrity of the data, concluding that this was a case of clerical error not modifying the interpretation of the results, asking the journal to issue an Erratum. Accordingly, the corrected Fig. 3 is now provided. All the authors of the article have agreed to the correction; they apologise for any inconvenience caused to the readers.

Original language	English
Article number	107463
Journal	Pharmacological Research
Volume	209
Early online date	2024
DOIs	https://doi.org/10.1016/j.phrs.2024.107463
Publication status	Published - Nov 2024

Access to Document

10.1016/j.phrs.2024.107463

Fingerprint

Dive into the research topics of 'Corrigendum to “Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation” [Pharmacol. Res. 159 (2020) 104944] (Pharmacological Research (2020) 159, (S1043661820312524), (10.1016/j.phrs.2020.104944))'. Together they form a unique fingerprint.

Cite this

Chen, D., Ye, Z., Wang, C., Wang, Q., Wang, H., Kuek, V., Wang, Z., Qiu, H., Yuan, J., Kenny, J., Yang, F., He, J., Liu, Y., Wang, G., Zhang, M., Zhang, G., Wang, J., Chen, P., & Xu, J. (2024). Corrigendum to “Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation” [Pharmacol. Res. 159 (2020) 104944] (Pharmacological Research (2020) 159, (S1043661820312524), (10.1016/j.phrs.2020.104944)). Pharmacological Research, 209, Article 107463. https://doi.org/10.1016/j.phrs.2024.107463

@article{94a260f1ed1247c195ba13d1be603839,

title = "Corrigendum to “Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation” [Pharmacol. Res. 159 (2020) 104944] (Pharmacological Research (2020) 159, (S1043661820312524), (10.1016/j.phrs.2020.104944))",

abstract = "The authors have informed the Journal that in the article referenced above, during the course of the revision a wrong image was uploaded as Fig. 3A left panel. The Ethics Committee of the Clifford Hospital was asked by the Editor to check the integrity of the results sustaining the above referenced article. The Committee has checked the raw data and confirmed in writing to the journal the integrity of the data, concluding that this was a case of clerical error not modifying the interpretation of the results, asking the journal to issue an Erratum. Accordingly, the corrected Fig. 3 is now provided. All the authors of the article have agreed to the correction; they apologise for any inconvenience caused to the readers.",

author = "Delong Chen and Zhen Ye and Chao Wang and Qingqing Wang and Haibin Wang and Vincent Kuek and Ziyi Wang and Heng Qiu and Jinbo Yuan and Jacob Kenny and Fan Yang and Jianbo He and Yun Liu and Gang Wang and Meng Zhang and Gangyu Zhang and Junjian Wang and Peng Chen and Jiake Xu",

year = "2024",

month = nov,

doi = "10.1016/j.phrs.2024.107463",

language = "English",

volume = "209",

journal = "Pharmacological Research",

issn = "1043-6618",

publisher = "Academic Press",

}

Chen, D, Ye, Z, Wang, C, Wang, Q, Wang, H, Kuek, V, Wang, Z, Qiu, H , Yuan, J , Kenny, J, Yang, F, He, J, Liu, Y, Wang, G, Zhang, M, Zhang, G, Wang, J, Chen, P & Xu, J 2024, 'Corrigendum to “Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation” [Pharmacol. Res. 159 (2020) 104944] (Pharmacological Research (2020) 159, (S1043661820312524), (10.1016/j.phrs.2020.104944))', Pharmacological Research, vol. 209, 107463. https://doi.org/10.1016/j.phrs.2024.107463

Corrigendum to “Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation” [Pharmacol. Res. 159 (2020) 104944] (Pharmacological Research (2020) 159, (S1043661820312524), (10.1016/j.phrs.2020.104944)). / Chen, Delong; Ye, Zhen; Wang, Chao et al.
In: Pharmacological Research, Vol. 209, 107463, 11.2024.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Corrigendum to “Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation” [Pharmacol. Res. 159 (2020) 104944] (Pharmacological Research (2020) 159, (S1043661820312524), (10.1016/j.phrs.2020.104944))

AU - Chen, Delong

AU - Ye, Zhen

AU - Wang, Chao

AU - Wang, Qingqing

AU - Wang, Haibin

AU - Kuek, Vincent

AU - Wang, Ziyi

AU - Qiu, Heng

AU - Yuan, Jinbo

AU - Kenny, Jacob

AU - Yang, Fan

AU - He, Jianbo

AU - Liu, Yun

AU - Wang, Gang

AU - Zhang, Meng

AU - Zhang, Gangyu

AU - Wang, Junjian

AU - Chen, Peng

AU - Xu, Jiake

PY - 2024/11

Y1 - 2024/11

N2 - The authors have informed the Journal that in the article referenced above, during the course of the revision a wrong image was uploaded as Fig. 3A left panel. The Ethics Committee of the Clifford Hospital was asked by the Editor to check the integrity of the results sustaining the above referenced article. The Committee has checked the raw data and confirmed in writing to the journal the integrity of the data, concluding that this was a case of clerical error not modifying the interpretation of the results, asking the journal to issue an Erratum. Accordingly, the corrected Fig. 3 is now provided. All the authors of the article have agreed to the correction; they apologise for any inconvenience caused to the readers.

AB - The authors have informed the Journal that in the article referenced above, during the course of the revision a wrong image was uploaded as Fig. 3A left panel. The Ethics Committee of the Clifford Hospital was asked by the Editor to check the integrity of the results sustaining the above referenced article. The Committee has checked the raw data and confirmed in writing to the journal the integrity of the data, concluding that this was a case of clerical error not modifying the interpretation of the results, asking the journal to issue an Erratum. Accordingly, the corrected Fig. 3 is now provided. All the authors of the article have agreed to the correction; they apologise for any inconvenience caused to the readers.

UR - http://www.scopus.com/inward/record.url?scp=85207030881&partnerID=8YFLogxK

U2 - 10.1016/j.phrs.2024.107463

DO - 10.1016/j.phrs.2024.107463

M3 - Comment/debate

C2 - 39448282

AN - SCOPUS:85207030881

SN - 1043-6618

VL - 209

JO - Pharmacological Research

JF - Pharmacological Research

M1 - 107463

ER -

Chen D, Ye Z, Wang C, Wang Q, Wang H, Kuek V et al. Corrigendum to “Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation” [Pharmacol. Res. 159 (2020) 104944] (Pharmacological Research (2020) 159, (S1043661820312524), (10.1016/j.phrs.2020.104944)). Pharmacological Research. 2024 Nov;209:107463. Epub 2024. doi: 10.1016/j.phrs.2024.107463

Corrigendum to “Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation” [Pharmacol. Res. 159 (2020) 104944] (Pharmacological Research (2020) 159, (S1043661820312524), (10.1016/j.phrs.2020.104944))

Abstract

Access to Document

Other files and links

Fingerprint

Cite this